Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.

Abstract

BACKGROUND Beidellitic montmorillonite is a purified clay containing a double aluminium and magnesium silicate. AIM To assess the efficacy and the safety of beidellitic montmorillonite (3 g, t.d. for 8 weeks) in patients with irritable bowel syndrome (IBS). METHODS A multicentre, double-blind, placebo-controlled, randomized study with parallel groups… (More)

Topics

  • Presentations referencing similar topics